Wednesday, July 8, 2026

pharma · Hemophilia A With Inhibitor · Hemophilia A · CPRX

CATALYST PHARMACEUTICALS

CATALYST PHARMACEUTICALS patent portfolio — 61 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

355 Alhambra Circle, Suite 801, Coral Gables, Florida 33134, US HQ
2002 Founded
179 Employees
Public company Type
CPRX · NYSE Ticker
Company details
Status
Public
HQ
355 Alhambra Circle, Suite 801, Coral Gables, Florida 33134, US
Founded
2002
Employees
179
Programs
23
Drugs
20
Patents
61
Intelligence · Patents

CATALYST PHARMACEUTICALS patents

61 pharmaceutical patents indexed for CATALYST PHARMACEUTICALS. 3 expire within 24 months.

CATALYST PHARMACEUTICALS has 61 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 3 expire within 24 months — use filters for patent-cliff planning.

Patent portfolio

Page 2 of 2
  1. US 7727602

    Recording sheet with ink receptive layer and coating liquid for forming ink receptive layer

    Expires Mon May 27 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. US 7695737

    Spherical composite particles and cosmetics with the particles blended therein

    Expires Mon Apr 08 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  3. US 7491677

    Combinatorial synthesis

    Expires Mon Feb 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  4. US 7318861

    Effect pigment

    Expires Mon Jan 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  5. US 7227009

    MT-SP1 polynucleotides and polypeptides

    Expires Mon May 31 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  6. US 7169726

    Catalyst for isomerization of solid fischer-tropsch paraffins and method for its production

    Expires Mon Jan 25 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  7. US 7030231

    Membrane type serine protease 1 (MT-SP1) and uses thereof

    Expires Mon Apr 13 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  8. US 6923974

    Flaky fine powder, production thereof, and cosmetic

    Expires Mon Jul 28 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  9. US 6849112

    Inorganic particles as a dental material and a method of producing the same

    Expires Mon Jan 27 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  10. US 6825259

    Resin-coated scale-like inorganic particles and cosmetics with the same blended therein

    Expires Mon Nov 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  11. US 6562323

    Composite powder, cosmetic and paint with the composite powder blended therein

    Expires Mon May 08 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  12. US 6482419

    Inorganic composite powder and cosmetic comprising the same

    Expires Mon Nov 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  13. US 6355260

    Inorganic compound-coated pigments and cosmetics using the same

    Expires Mon Mar 07 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many patents does CATALYST PHARMACEUTICALS have?

61 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do CATALYST PHARMACEUTICALS patents expire?

3 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.